Expert Review of Vaccines

SJR Rank #3,237H-index: 117SJR: 1.280Best quartile: Q1Open AccessListed in DOAJ
Journal website: aims, scope and author guidelines
Publisher

Taylor and Francis Ltd.

Country

United Kingdom

Type

journal

SJR by Edition

2022202500.350.71.051.4

Subject Categories

  • Drug DiscoveryQ1
  • PharmacologyQ1
  • ImmunologyQ2
  • Molecular MedicineQ2

Areas: Biochemistry, Genetics and Molecular Biology · Immunology and Microbiology · Pharmacology, Toxicology and Pharmaceutics

Most published research topics

Immunotherapy and Immune ResponsesInfluenza Virus Research StudiesVaccine Coverage and HesitancyRespiratory viral infections researchPneumonia and Respiratory Infectionsvaccines and immunoinformatics approachesSARS-CoV-2 and COVID-19 ResearchViral gastroenteritis research and epidemiologyBacterial Infections and VaccinesHepatitis B Virus Studies

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs095190285380

Documents per Year

2022202504590135180

Detailed Information

ISSN

1476-0584, 1744-8395

SJR Best Quartile

Q1

Region

Western Europe

Citations per Document (2 years)

5.48

References per Document

63.94

Coverage

2002-2026

Scope

Expert Review of Vaccines (ISSN 1476-0584) provides expert commentary on the development, application, and clinical effectiveness of new vaccines. Coverage includes vaccine technology, vaccine adjuvants, prophylactic vaccines, therapeutic vaccines, AIDS vaccines and vaccines for defence against bioterrorism. All articles are subject to rigorous peer-review. The vaccine field has been transformed by recent technological advances, but there remain many challenges in the delivery of cost-effective, safe vaccines. Expert Review of Vaccines facilitates decision making to drive forward this exciting field.

Metrics from SCImago Journal Rank 2025. View on SCImago